Difference between revisions of "OctPGMS pathway control state"
From Bioblast
| (7 intermediate revisions by 4 users not shown) | |||
| Line 3: | Line 3: | ||
|description='''OctPGMS''': [[Octanoylcarnitine]] & [[Pyruvate]] & [[Glutamate]] & [[Malate]] & [[Succinate]]. | |description='''OctPGMS''': [[Octanoylcarnitine]] & [[Pyruvate]] & [[Glutamate]] & [[Malate]] & [[Succinate]]. | ||
'''MitoPathway control:''' | '''MitoPathway control state:''' [[FNS]] | ||
'''SUIT protocol:''' [[ | '''SUIT protocol:''' [[SUIT-001]], [[SUIT-002]], [[SUIT-015]] | ||
This substrate combination supports convergent electron flow to the [[Q-junction]]. | This substrate combination supports convergent electron flow to the [[Q-junction]]. | ||
|info=[[MiPNet21.06 SUIT | |info=[[MiPNet21.06 SUIT RP]], [[SUIT reference protocol]] | ||
}} | }} | ||
::: ''More details'' | |||
| | ::::» [[FNS]] | ||
::::» [[Additive effect of convergent electron flow]] | |||
::::» [[Respiratory_complexes#Respiratory_complexes_-_more_than_five |Respiratory complexes - more than five]] | |||
::::» [[OctPGM pathway control state]] | |||
::::» [[Convergent electron flow]] | |||
== | == OctPMS<sub>''L''</sub> == | ||
FNS pathway in the LEAK state can be evaluated in the following SUIT protocols: | |||
== OctPMS<sub>''P''</sub> == | |||
FNS pathway in the OXPHOS state can be evaluated in the following SUIT protocols: | |||
:::*[[SUIT-002]] | |||
::::* DL-Protocol for isolated mitochondria and tissue homogenate (mt): [[SUIT-002 O2 mt D005]] | |||
::::* DL-Protocol for permeabilized fibers (pfi): [[SUIT-002 O2 pfi D006]] | |||
::::* DL-Protocol for permeabilized cells (pce): [[SUIT-002 O2 ce-pce D007]] | |||
:::*[[SUIT-015]] | |||
== OctPMS<sub>''E''</sub> == | |||
FNS pathway in the ET state can be evaluated in the following SUIT protocols: | |||
:::*[[SUIT-001]] | |||
::::* DL-Protocol for isolated mitochondria and tissue homogenate (mt): [[SUIT-001 O2 mt D001]] | |||
::::* DL-Protocol for permeabilized fibers (pfi): [[SUIT-001 O2 pfi D002]] | |||
::::* DL-Protocol for permeabilized cells (pce): [[SUIT-001 O2 ce-pce D003]] | |||
:::*[[SUIT-015]] | |||
---- | ---- | ||
[[File:SUIT-Reference-Protocol 1.jpg|700px |SUIT RP1]]<br /> | [[File:SUIT-Reference-Protocol 1.jpg|700px |SUIT RP1]]<br /> | ||
| Line 30: | Line 41: | ||
[[File:SUIT-Reference-Protocol 2.jpg|700px |SUIT RP2]]<br /> | [[File:SUIT-Reference-Protocol 2.jpg|700px |SUIT RP2]]<br /> | ||
---- | ---- | ||
{{MitoPedia concepts | |||
|mitopedia concept=SUIT state | |||
}} | |||
Latest revision as of 05:01, 19 July 2022
- high-resolution terminology - matching measurements at high-resolution
OctPGMS pathway control state
Description
OctPGMS: Octanoylcarnitine & Pyruvate & Glutamate & Malate & Succinate.
MitoPathway control state: FNS
SUIT protocol: SUIT-001, SUIT-002, SUIT-015
This substrate combination supports convergent electron flow to the Q-junction.
Abbreviation: OctPGMS
Reference: MiPNet21.06 SUIT RP, SUIT reference protocol
OctPMSL
FNS pathway in the LEAK state can be evaluated in the following SUIT protocols:
OctPMSP
FNS pathway in the OXPHOS state can be evaluated in the following SUIT protocols:
-
- DL-Protocol for isolated mitochondria and tissue homogenate (mt): SUIT-002 O2 mt D005
- DL-Protocol for permeabilized fibers (pfi): SUIT-002 O2 pfi D006
- DL-Protocol for permeabilized cells (pce): SUIT-002 O2 ce-pce D007
-
OctPMSE
FNS pathway in the ET state can be evaluated in the following SUIT protocols:
-
- DL-Protocol for isolated mitochondria and tissue homogenate (mt): SUIT-001 O2 mt D001
- DL-Protocol for permeabilized fibers (pfi): SUIT-001 O2 pfi D002
- DL-Protocol for permeabilized cells (pce): SUIT-001 O2 ce-pce D003
-
MitoPedia concepts:
SUIT state
